Relevium Technologies Inc. (RLLVF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2021 | -1.47 Million CAD | 31.39% |
| 2020 | -2.14 Million USD | 29.9% |
| 2019 | -3.17 Million USD | -65.87% |
| 2018 | -1.94 Million CAD | -38.52% |
| 2017 | -1.33 Million CAD | -80.97% |
| 2016 | -735.5 Thousand CAD | -242.76% |
| 2015 | -214.58 Thousand CAD | 1.86% |
| 2014 | -218.65 Thousand CAD | 7.82% |
| 2013 | -237.21 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 Q3 | 857.86 Thousand CAD | 0.0% |
| 2021 FY | - CAD | 31.39% |
| 2021 Q1 | -288.21 Thousand CAD | 84.56% |
| 2021 Q2 | -456.84 Thousand CAD | -58.51% |
| 2021 Q3 | -319.89 Thousand CAD | 29.98% |
| 2021 Q4 | -323.69 Thousand CAD | -1.19% |
| 2020 FY | - USD | 29.9% |
| 2020 Q3 | 9016.00 CAD | 102.45% |
| 2020 Q2 | -367.84 Thousand CAD | 58.33% |
| 2020 Q1 | -882.8 Thousand CAD | 6.63% |
| 2020 Q4 | -1.86 Million CAD | -20806.91% |
| 2019 Q2 | -678.08 Thousand CAD | -39.96% |
| 2019 Q1 | -484.49 Thousand CAD | 25.56% |
| 2019 FY | - USD | -65.87% |
| 2019 Q4 | -945.49 Thousand CAD | 3.76% |
| 2019 Q3 | -982.45 Thousand CAD | -44.89% |
| 2018 Q3 | -488.29 Thousand CAD | 30.01% |
| 2018 Q2 | -697.64 Thousand CAD | -9840.74% |
| 2018 FY | - CAD | -38.52% |
| 2018 Q1 | -7018.00 CAD | 99.47% |
| 2018 Q4 | -650.81 Thousand CAD | -33.28% |
| 2017 Q2 | -140.95 Thousand CAD | 14.55% |
| 2017 FY | - CAD | -80.97% |
| 2017 Q4 | -1.31 Million CAD | -604.22% |
| 2017 Q3 | -186.66 Thousand CAD | -32.43% |
| 2017 Q1 | -164.95 Thousand CAD | -141.92% |
| 2016 FY | - CAD | -242.76% |
| 2016 Q2 | -253.92 Thousand CAD | -31.82% |
| 2016 Q1 | -192.63 Thousand CAD | -183.81% |
| 2016 Q4 | 393.54 Thousand CAD | 285.11% |
| 2016 Q3 | -212.6 Thousand CAD | 16.27% |
| 2015 Q4 | -67.87 Thousand CAD | -196.96% |
| 2015 FY | - CAD | 1.86% |
| 2015 Q3 | -22.85 Thousand CAD | 41.81% |
| 2015 Q2 | -39.27 Thousand CAD | 37.71% |
| 2015 Q1 | -63.05 Thousand CAD | 1.63% |
| 2014 Q1 | -46.17 Thousand CAD | 0.0% |
| 2014 Q3 | -29.77 Thousand CAD | 62.13% |
| 2014 Q4 | -64.09 Thousand CAD | -115.28% |
| 2014 FY | - CAD | 7.82% |
| 2014 Q2 | -78.61 Thousand CAD | -70.28% |
| 2013 Q2 | -118.21 Thousand CAD | 0.0% |
| 2013 Q3 | -18.11 Thousand CAD | 84.67% |
| 2013 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -251.11 USD | -585618.609% |
| Allstar Health Brands, Inc. | -241.78 Thousand USD | -508.303% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | 101.645% |
| Café Serendipity Holdings, Inc. | -1.41 Million USD | -3.922% |
| Decision Diagnostics Corp. | - USD | Infinity% |
| Health Advance Inc. | -47.95 Thousand USD | -2966.846% |
| HealthWarehouse.com, Inc. | -1.27 Million USD | -15.329% |
| LIGAND PHARMACEUTICAL INC | 47.23 Million USD | 103.114% |
| MedGen, Inc. | -15.37 USD | -9569177.814% |
| Omni Health, Inc. | 1.28 Million USD | 214.228% |
| Oxford Investments Holdings Inc. | -343.96 Thousand USD | -327.6% |
| Pineapple, Inc. | -1.47 Million USD | 0.304% |
| ScripsAmerica, Inc. | -3.95 Million USD | 62.807% |